Haystack Oncology specializes in advanced tumor-informed minimal residual disease (MRD) testing that detects circulating tumor DNA (ctDNA) in blood, providing high precision and sensitivity for cancer detection and monitoring
Haystack Oncology specializes in advanced tumor-informed minimal residual disease (MRD) testing that detects circulating tumor DNA (ctDNA) in blood, providing high precision and sensitivity for cancer detection and monitoring.